Applied BioCode Corporation Stock

Equities

6598

KYG0488D1051

Biotechnology & Medical Research

End-of-day quote Taiwan S.E. 06:00:00 2024-07-14 pm EDT 5-day change 1st Jan Change
26.3 TWD -3.31% Intraday chart for Applied BioCode Corporation -12.33% +3.95%
Sales 2024 * 430M 13.2M Sales 2025 * - Capitalization 2.15B 66.01M
Net income 2024 * -145M -4.45M Net income 2025 * - EV / Sales 2024 * 5 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-14.8 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only CI
Applied BioCode Announces CEO Changes CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer CI
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Applied BioCode Corporation Announces the Change of Representative of Institutional Director CI
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer CI
More news
1 day-3.31%
1 week-12.33%
Current month-14.05%
1 month+25.54%
3 months+25.24%
6 months+7.57%
Current year+3.95%
More quotes
1 week
25.65
Extreme 25.65
30.95
1 month
21.15
Extreme 21.15
33.60
Current year
19.20
Extreme 19.2
33.60
1 year
19.20
Extreme 19.2
33.60
3 years
19.20
Extreme 19.2
60.70
5 years
19.20
Extreme 19.2
182.50
10 years
19.20
Extreme 19.2
182.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 07-12-31
Director of Finance/CFO - 18-01-31
Chief Tech/Sci/R&D Officer - 23-02-28
Members of the board TitleAgeSince
Chairman 73 16-06-29
Director/Board Member 58 16-09-28
Director/Board Member - 16-09-28
More insiders
Date Price Change Volume
24-07-14 26.3 -3.31% 555 443
24-07-12 27.2 -5.88% 681,071
24-07-11 28.9 -0.52% 479,859
24-07-10 29.05 -2.84% 472,966
24-07-09 29.9 -3.55% 728,275

End-of-day quote Taiwan S.E., July 14, 2024

More quotes
Applied BioCode Corp is engaged in the provision of digital biological barcode detection technology platforms and related products. The Company's products mainly include digital biological barcodes, optical analyzers, in vitro diagnostic reagents, and others. The Company sells products in the United States, Europe and Asian markets.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
26.3 TWD
Average target price
22 TWD
Spread / Average Target
-16.35%
Consensus